Gilead Sciences Presents at ECCMID 2022 - Continues Mission to Advance Access to Effective Therapies

Multimedia with summary

The data we presented at ECCMID 2022 is part of Gilead’s mission to advance access to effective therapies. We've helped transform the treatment and prevention of HIV and delivered HCV cures as a result of our deep scientific understanding of viruses and expertise in antiviral drug development.

View original content here.

Subscribe to ECCMID 2022